1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Atrial Fibrillation Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Treatment Type ; End User ; and Geography

Atrial Fibrillation Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Treatment Type ; End User ; and Geography

  • August 2020
  • 150 pages
  • ID: 5967870
  • Format: PDF
  • The Insight Partners
Up to $1700 off Until Oct 31st 2020

Summary

Table of Contents

Search Inside

The global Atrial Fibrillation is expected to reach US$ 18,085.96 Mn in 2027 from US$ 6,446.08 Mn in 2019. The market is estimated to grow with a CAGR of 14.0% from 2020-2027.

Driving factors of the Atrial Fibrillation market are increasing prevalence of atrial fibrillation and rising awareness regarding atrial fibrillation are expected to boost the market growth over the years.Besides, development opportunities in emerging countries is expected to have a positive effect on the growth of the market in the forecast years.

However, high cost of atrial fibrillation devices and procedures is likely to have negative impact on the growth of the market in the coming years.

Atrial fibrillation is among the most commonly occurring heart condition, which causes irregular and often abnormally fast heart rates, which can lead to the possibility of a stroke.A large number of populations across the globe are unaware of the symptoms associated with atrial fibrillation and hence remain untreated.

As per Eastern AHSN, across England, approximately 425,000 people are living with undiagnosed and untreated AF.Various associations across the world have been involved in undertaking awareness regarding the medical condition.

For instance, Health Innovation Manchester in November 2018 raised awareness regarding Atrial Fibrillation and other innovative technologies to increase the detection of the disease as part of the Global AF Aware Week.

Other than bodies such as associations and organizations, companies in the market have also played an instrumental role in increasing the awareness regarding atrial fibrillation.For instance, Biosense Webster, a Division of Johnson & Johnson, launched two major initiatives as a part of the Global AF Aware Week, which falls between 18-24 November.

As a part of the action named Get Smart About AFIB (GSAAF), the company entered into a strategic partnership with the Arrhythmia Alliance to increase knowledge of AF across the healthcare community and the general public. As awareness helps in improving the medical care needed for the treatment of atrial fibrillation, the market is expected to witness considerable growth during the forecast period.

The global Atrial Fibrillation is segmented by treatment type and end user.The atrial fibrillation market, by treatment type, is segmented into non-pharmacological and pharmacological.

The non-pharmacological segment held the largest share of the market in 2019. The segment is also anticipated to register the highest CAGR in the market during the forecast period.

Based on end-user, the atrial fibrillation market is segmented into hospitals, ambulatory surgical centers and cardiac catheterization laboratories.The hospitals segment held the largest share of the market in 2019.

In addition, the segment is also estimated to register the highest CAGR in the market during the forecast period.

Some of the essential primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), World Stroke Organization, Health Authority of Abu Dhabi, European Heart Network among others.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off

($4500)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Injectable Drugs Market - Growth, Trends, and Forecasts (2020 - 2025)

  • $ 4250
  • September 2020
  • 134 pages

The injectable drugs market is expected to register a CAGR of nearly 11.1% during the forecast period. With an upsurge in the number of chronic diseases like diabetes and cancer, the need for drug delivery ...

  • World
  • APAC
  • Pharmaceutical
  • Infectious Disease
  • Industry analysis
  • Drug Approval
  • Diabetes Prevalence

ref:plp2020

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on